Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil adjunctive therapy for focal-onset seizures in drug-resistant epilepsy
jRCT2080224661Phase 3Completed
- Sponsor
- UCB
- Start
- May 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in refractory focal epilepsy comparing Padsevonil adjunctive arm with Placebo adjunctive arm (2 arms). Started May 2019; status: completed.
02
Drugs
padsevonil
03
Conditions
refractory focal epilepsy
Beyond the preview
Go deeper on jRCT2080224661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224661.